|
发表于 2022-12-11 09:57:43
|
显示全部楼层
The invention provides a method to detectably enhance an antigen specific immune response, cell mediated immune response or a delayed type hypersensitivity immune response in a subject having impaired or negligible antigen specific immune response, cell mediated immune response or delayed type hypersensitivity immune response, comprising administering to the subject, or delivering to the subject s tissues, an effective amount of a F1C <a href=http://accutane.one>claravis accutane</a> Treatment includes drug discontinuation, supportive care and potentially corticosteroids |
|